China has become a key contributor to absolute value growth in global revenues of the healthcare industry. CWC advises pharmaceutical and medical device companies on market entry strategies and broadening of market share, sourcing of manufacturing facilities and distribution platforms, support of SFDA approvals and regulatory issues, as well as facilitation of clinical trials in China. CWC has developed a broad understanding of the health care sector in China and...
CWC Strategy
